Neumora Therapeutics, Inc.(NMRA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NMRA Neumora Therapeutics, Inc.

已收盘 11-15 16:00:00 EST

10.84

-0.85

-7.27%

盘后10.84

+0.00+0.00%

19:42 EST

最高11.77	最低10.74	成交量95.66万
今开11.74	昨收11.69	日振幅8.81%
总市值17.51亿	流通市值9.13亿	总股本1.62亿
成交额1,047万	换手率1.14%	流通股本8,419万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"NMRA","market":"US","secType":"STK","nameCN":"Neumora Therapeutics, Inc.","latestPrice":10.84,"timestamp":1731704400000,"preClose":11.69,"halted":0,"volume":956648,"hourTrading":{"tag":"盘后","latestPrice":10.8396,"preClose":10.84,"latestTime":"19:42 EST","volume":17721,"amount":192097.2,"timestamp":1731717723469},"delay":0,"floatShares":84185819,"shares":161561064,"eps":-1.863829,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.85,"latestTime":"11-15 16:00:00 EST","open":11.74,"high":11.77,"low":10.74,"amount":10469231.408328,"amplitude":0.088109,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.863829,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1731920400000},"adr":0,"listingDate":1694750400000,"adjPreClose":11.69,"preHourTrading":{"tag":"盘前","latestPrice":11.76,"preClose":11.69,"latestTime":"09:28 EST","volume":1,"amount":11.76,"timestamp":1731680880102},"postHourTrading":{"tag":"盘后","latestPrice":10.8396,"preClose":10.84,"latestTime":"19:42 EST","volume":17721,"amount":192097.2,"timestamp":1731717723469},"volumeRatio":0.702983,"optionData":{"bulkOrders":[{"symbol":"NMRA","call":true,"expireDate":1737090000000,"strike":"15.0","timestamp":1731689650811,"price":4,"volume":5000,"amount":2000000,"type":"+"},{"symbol":"NMRA","call":false,"expireDate":1737090000000,"strike":"10.0","timestamp":1731689858445,"price":4.25,"volume":1027,"amount":436475,"type":"-"}]},"impliedVol":2.2909,"impliedVolPercentile":0.9405},"requestUrl":"/m/hq/s/NMRA","defaultTab":"news","newsList":[{"id":"2481541559","title":"美国研究综述-信诺、万豪、拉尔夫-劳伦","url":"https://stock-news.laohu8.com/highlight/detail?id=2481541559","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481541559?lang=zh_cn&edition=full","pubTime":"2024-11-05 15:04","pubTimestamp":1730790257,"startTime":"0","endTime":"0","summary":"    路透11月5日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 Cigna、万豪和 Ralph Lauren。要闻             * Cigna   ：Piper Sandler将目标价从392美元上调至394美元             * 万豪  ：杰富瑞将目标价从 225 美元上调至 251 美元              * Ralph Lauren Corp   ：TD Cowen 将目标价从 208 美元上调至 251 美元              * Vertex Pharmaceuticals Inc   ：丰业银行将目标价从480美元上调至486美元             * Wynn Resorts Ltd   ：摩根大通将目标价从101美元上调至113美元  以下是路透周二报导的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ1G4Q59.USD","EVER","KROS","LU1363072403.SGD","LU1489326972.SGD","BK4106","EDIT","MDGL","SHAK","ST","EGHT","BWIN","GKOS","ATUS","NMRA","CSTL","ILMN","IRON","RL","SM","SLAB","BMRN","CMS","RZLT","HIMS","LU0971096721.USD","LSCC","FOXA","OMI","AMG","FRPT","BEN","AWI","LU","CI","LU0149725797.USD","LU1244550221.USD","NYT","LU0266512127.USD","INSP","MAR","LU0949170772.SGD","LU0320765489.SGD","ARES","FIS","PTGX","CAMP"],"gpt_icon":1},{"id":"2481415545","title":"美国研究综述-信诺、万豪、拉尔夫-劳伦","url":"https://stock-news.laohu8.com/highlight/detail?id=2481415545","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481415545?lang=zh_cn&edition=full","pubTime":"2024-11-05 15:04","pubTimestamp":1730790257,"startTime":"0","endTime":"0","summary":"    路透11月5日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 Cigna、万豪和 Ralph Lauren。要闻             * Cigna   ：Piper Sandler将目标价从392美元上调至394美元             * 万豪  ：杰富瑞将目标价从 225 美元上调至 251 美元              * Ralph Lauren Corp   ：TD Cowen 将目标价从 208 美元上调至 251 美元              * Vertex Pharmaceuticals Inc   ：丰业银行将目标价从480美元上调至486美元             * Wynn Resorts Ltd   ：摩根大通将目标价从101美元上调至113美元  以下是路透周二报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BWIN","AWI","EGHT","GKOS","EDIT","FIS","IE00BZ1G4Q59.USD","ILMN","LU1244550221.USD","BMRN","CI","CSTL","SM","EVER","IRON","LU0949170772.SGD","NMRA","LU1363072403.SGD","LSCC","LU1489326972.SGD","INSP","BK4106","KROS","RZLT","OMI","AMG","FRPT","LU0266512127.USD","CMS","MAR","SLAB","LU","MDGL","BEN","LU0320765489.SGD","PTGX","CAMP","RL","SHAK","NYT","LU0971096721.USD","ST","FOXA","ATUS","LU0149725797.USD","ARES"],"gpt_icon":1},{"id":"2481553446","title":"Neumora Therapeutics, Inc.盘中异动 股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481553446","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481553446?lang=zh_cn&edition=full","pubTime":"2024-11-05 01:33","pubTimestamp":1730741616,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日01时33分，Neumora Therapeutics, Inc.股票出现波动，股价快速拉升5.10%。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，其成立的目的是通过采取一种完全不同的方法来开发脑部疾病的治疗方法，以应对全球脑部疾病危机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110501333798e4054c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110501333798e4054c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NMRA","BK4007","LENZ"],"gpt_icon":0},{"id":"2480083599","title":"实时市场-脑力劳动正在进行，但神经药物开发人员仍需努力","url":"https://stock-news.laohu8.com/highlight/detail?id=2480083599","media":"Reuters","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480083599?lang=zh_cn&edition=full","pubTime":"2024-11-01 23:38","pubTimestamp":1730475534,"startTime":"0","endTime":"0","summary":"您可以通过以下网址与我们分享您的想法  脑力劳动正在进行，但神经药物开发商仍有很长的路要走Canaccord Genuity分析师周五表示，神经系统疾病方面的需求尚未得到满足，这激起了人们对正在开发的治疗抑郁症、阿尔茨海默病和痴呆症等神经系统疾病药物试验数据的期待，这些疾病影响着全球数百万患者。嘉能可补充说，尽管在理解阿尔茨海默氏症这种神经退行性疾病方面还存在挑战，但 Leqembi 和 Kisunla 的成功已经到来。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0122379950.USD","IE00BJJMRZ35.SGD","IE00B42XCP33.USD","BK4532","DJX","LU0943347566.SGD","IE00B19Z9Z06.USD","SQQQ","LU0097036916.USD","LU0320765646.SGD","LU0203201768.USD",".SPX","QLD","IE0034235303.USD","MNQmain","LU0354030511.USD","LU0417517546.SGD","DXD","DOG","LU0096364046.USD",".DJI","IE00B2B36J28.USD","UDOW","BK4581","BMY",".IXIC","BK4504","LU0094547139.USD","JNJ","LU1064131342.USD","CRVO","DDM","NQmain","IE00BFTCPJ56.SGD","NMRA","PSQ","LU0795875086.SGD","QID","SDOW","TQQQ","LU0456855351.SGD","BK4139","LU1066051225.USD","BIIB","LU0061475181.USD","LU0203347892.USD","LU0708995401.HKD","LU0234570918.USD"],"gpt_icon":1},{"id":"2480066288","title":"Neumora Therapeutics, Inc.盘中异动 临近收盘急速下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480066288","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480066288?lang=zh_cn&edition=full","pubTime":"2024-11-01 03:55","pubTimestamp":1730404540,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日03时55分，Neumora Therapeutics, Inc.股票出现异动，股价快速跳水5.00%。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为3.00%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，其成立的目的是通过采取一种完全不同的方法来开发脑部疾病的治疗方法，以应对全球脑部疾病危机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101035540971a39ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101035540971a39ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NMRA","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2478952275","title":"Neumora Therapeutics, Inc.盘中异动 下午盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478952275","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478952275?lang=zh_cn&edition=full","pubTime":"2024-10-26 02:02","pubTimestamp":1729879329,"startTime":"0","endTime":"0","summary":"北京时间2024年10月26日02时02分，Neumora Therapeutics, Inc.股票出现波动，股价急速下挫5.00%。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.63%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，其成立的目的是通过采取一种完全不同的方法来开发脑部疾病的治疗方法，以应对全球脑部疾病危机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026020210ab7483f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026020210ab7483f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NMRA","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2477823865","title":"Neumora Therapeutics, Inc.盘中异动 早盘股价大跌5.28%报15.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477823865","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477823865?lang=zh_cn&edition=full","pubTime":"2024-10-21 21:30","pubTimestamp":1729517455,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日21时30分，Neumora Therapeutics, Inc.股票出现异动，股价急速跳水5.28%。截至发稿，该股报15.62美元/股，成交量3.6157万股，换手率0.02%，振幅0.79%。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，其成立的目的是通过采取一种完全不同的方法来开发脑部疾病的治疗方法，以应对全球脑部疾病危机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021213055971a15af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021213055971a15af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","NMRA","BK4139"],"gpt_icon":0},{"id":"2472526763","title":"Neumora Therapeutics, Inc.盘中异动 早盘快速下跌5.19%报12.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472526763","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472526763?lang=zh_cn&edition=full","pubTime":"2024-10-02 21:32","pubTimestamp":1727875922,"startTime":"0","endTime":"0","summary":"北京时间2024年10月02日21时32分，Neumora Therapeutics, Inc.股票出现异动，股价急速跳水5.19%。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.01%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，其成立的目的是通过采取一种完全不同的方法来开发脑部疾病的治疗方法，以应对全球脑部疾病危机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241002213202ab67757b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241002213202ab67757b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NMRA","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2453754549","title":"Neumora Therapeutics Inc：Needham发起覆盖评定为买入目标价23美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2453754549","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453754549?lang=zh_cn&edition=full","pubTime":"2024-07-22 17:37","pubTimestamp":1721641022,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["NMRA","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2449778033","title":"Neumora Therapeutics(NMRA.US)获瑞穗银行首次覆盖，给予优于大市评级, 目标价20.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2449778033","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449778033?lang=zh_cn&edition=full","pubTime":"2024-07-08 18:46","pubTimestamp":1720435604,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4007","LENZ","NMRA","161121","BK4139"],"gpt_icon":0},{"id":"2449244857","title":"Neumora Therapeutics Inc: 瑞穗启动覆盖评级为跑赢大市；目标价为20美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2449244857","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449244857?lang=zh_cn&edition=full","pubTime":"2024-07-08 17:36","pubTimestamp":1720431395,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","BK4007","NMRA","LENZ"],"gpt_icon":0},{"id":"2436612841","title":"美国研究综述-阿里斯塔网络公司、新月能源公司、戴尔科技公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2436612841","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2436612841?lang=zh_cn&edition=full","pubTime":"2024-05-20 14:56","pubTimestamp":1716188173,"startTime":"0","endTime":"0","summary":"    路透5月20日 - 华尔街证券分析师周一调整了对几家美国上市公司的评级和目标价，其中包括 Arista Networks、Crescent Energy 和戴尔科技。* 戴尔科技公司  ：摩根大通将目标价从125美元上调至155美元              * Loar Holdings Inc   ：加拿大皇家银行给予 \"跑赢大盘 \"评级；目标价60美元              * Regeneron Pharmaceuticals Inc   ：Jefferies将其目标价从1,060美元上调至1,115美元。* 安特罗资源公司  ：Gerdes Energy Research将其评级从 \"买入 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DELL","LITE","LU1917777945.USD","LU2023250504.SGD","IE00BMPRXN33.USD","AR","BHVN","LOAR","PRMW","BK4213","SNOW","ANET","BK4121","BK4170","REGN","EWTX","BK4503","LU1803068979.SGD","IE00BMPRXR70.SGD","BK4585","LU2106854487.HKD","BK4581","HCAT","BK4515","KGS","LU0289739343.SGD","LU0289961442.SGD","FTRE","LU0114720955.EUR","LU0289739699.SGD","LU0109392836.USD","BK4505","NMRA","BK4007","BK4139","FLO","DAR","LU0109394709.USD","BK4182","AZZ","BK4588","LU0889565916.HKD","LU1974910355.USD","BK4551","BK4212","BK4020","CRGY","BK4177","BK4559","IIPR"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.neumoratx.com","stockEarnings":[{"period":"1week","weight":-0.1022},{"period":"1month","weight":-0.273},{"period":"3month","weight":0.0373},{"period":"6month","weight":0.2089},{"period":"1year","weight":-0.0266},{"period":"ytd","weight":-0.3144}],"compareEarnings":[{"period":"1week","weight":-0.0038},{"period":"1month","weight":0.0234},{"period":"3month","weight":0.0704},{"period":"6month","weight":0.1207},{"period":"1year","weight":0.3195},{"period":"ytd","weight":0.2483}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Neumora Therapeutics, Inc.成立于2019年11月，当时是一家特拉华州公司，名称为RBNC Therapeutics, Inc.。该公司于2021年10月更名为Neumora Therapeutics, Inc.。该公司是一家临床阶段的生物制药公司，旨在应对全球脑部疾病危机，对脑部疾病的治疗方法采取一种根本不同的方法。该公司的治疗管道规模迅速扩大，目前包括七个临床和临床前神经科学项目，针对广泛的未得到充分服务的神经精神疾病和神经退行性疾病的新的作用机制。该公司最先进的候选产品navacaprant（NMRA-140）是一种新型的每日一次口服kappa阿片受体（KOR）拮抗剂，正在开发用于治疗重度抑郁症（MDD），他们认为，如果获得批准，这种药物有可能提供相对于标准护理的显著优势。","exchange":"NASDAQ","name":"Neumora Therapeutics, Inc.","nameEN":"Neumora Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Neumora Therapeutics, Inc.(NMRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Neumora Therapeutics, Inc.(NMRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Neumora Therapeutics, Inc.,NMRA,Neumora Therapeutics, Inc.股票,Neumora Therapeutics, Inc.股票老虎,Neumora Therapeutics, Inc.股票老虎国际,Neumora Therapeutics, Inc.行情,Neumora Therapeutics, Inc.股票行情,Neumora Therapeutics, Inc.股价,Neumora Therapeutics, Inc.股市,Neumora Therapeutics, Inc.股票价格,Neumora Therapeutics, Inc.股票交易,Neumora Therapeutics, Inc.股票购买,Neumora Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Neumora Therapeutics, Inc.(NMRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Neumora Therapeutics, Inc.(NMRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}